Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer
Recruiting
N/A
Interventional Study
NMIBC
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 72 (estimated)
- Sponsor
- Changhai Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Residual tumors after transurethral resection of bladder tumors (TURBT) range from 17-70%, and floating tumor cells from traditional segmental resection may lead to recurrence if they re-implant in the bladder wall. Immediate systemic chemotherapy post-surgery aims to eliminate microlesions promptly and minimize recurrence risk, yet its safety and efficacy require further exploration. This prospec…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with a history and cystoscopy results indicating high-risk NMIBC:
* High-grade T1
* Any recurrent high-grade Ta
* High-grade Ta \& Tumor diameter greater than 3 cm or multifocal
* Any CIS
* Any BCG failure in patients with high-grade disease
* Any var…
Contacts